Catecholaminergic polymorphic ventricular tachycardia surgery: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Catecholaminergic polymorphic ventricular tachycardia }} | {{Catecholaminergic polymorphic ventricular tachycardia }} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MRV}} | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with catecholaminergic polymorphic ventricular tachycardia. [[Sympathectomy]] is usually reserved for patients who experience recurrent [[symptoms]] and/or [[implantable cardioverter-defibrillator]] ([[ICD]]) shocks despite optimal medical therapy or in those who are intolerant or have contraindications to [[beta blockers]] | |||
Surgery is not the first-line treatment option for patients with | |||
==Surgery== | ==Surgery== | ||
===Sympathectomy=== | |||
*Left [[cardiac]] [[sympathetic]] [[denervation]], where a portion of the [[sympathetic chain]] is [[surgical|surgically]] or [[endoscopic|endoscopically]] resected, and bilateral [[thoracoscopy|thoracoscopic]] [[sympathectomy]] have reported to be useful therapeutic methods for suppressing [[ventricular arrhythmias]] in [[CPVT]] patients.<ref name="PrioriBlomström-Lundqvist2015">{{cite journal|last1=Priori|first1=Silvia G.|last2=Blomström-Lundqvist|first2=Carina|last3=Mazzanti|first3=Andrea|last4=Blom|first4=Nico|last5=Borggrefe|first5=Martin|last6=Camm|first6=John|last7=Elliott|first7=Perry Mark|last8=Fitzsimons|first8=Donna|last9=Hatala|first9=Robert|last10=Hindricks|first10=Gerhard|last11=Kirchhof|first11=Paulus|last12=Kjeldsen|first12=Keld|last13=Kuck|first13=Karl-Heinz|last14=Hernandez-Madrid|first14=Antonio|last15=Nikolaou|first15=Nikolaos|last16=Norekvål|first16=Tone M.|last17=Spaulding|first17=Christian|last18=Van Veldhuisen|first18=Dirk J.|title=2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death|journal=European Heart Journal|volume=36|issue=41|year=2015|pages=2793–2867|issn=0195-668X|doi=10.1093/eurheartj/ehv316}}</ref><ref name="SchneiderSteinmetz2012">{{cite journal|last1=Schneider|first1=Heike E.|last2=Steinmetz|first2=Michael|last3=Krause|first3=Ulrich|last4=Kriebel|first4=Thomas|last5=Ruschewski|first5=Wolfgang|last6=Paul|first6=Thomas|title=Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome|journal=Clinical Research in Cardiology|volume=102|issue=1|year=2012|pages=33–42|issn=1861-0684|doi=10.1007/s00392-012-0492-7}}</ref><ref>{{cite journal|title=Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy|journal=Heart Rhythm|date=October 2008|first=P.A.|last=Scott|coauthors=A.J. Sandilands, G.E. Morris, J.M. Morgan |volume=5|issue=10|pages=1461–1463|pmid=18760972 |url=|format=|doi=10.1016/j.hrthm.2008.07.007 }}</ref><ref name="ColluraJohnson2009">{{cite journal|last1=Collura|first1=Christopher A.|last2=Johnson|first2=Jonathan N.|last3=Moir|first3=Christopher|last4=Ackerman|first4=Michael J.|title=Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery|journal=Heart Rhythm|volume=6|issue=6|year=2009|pages=752–759|issn=15475271|doi=10.1016/j.hrthm.2009.03.024}}</ref> | |||
*Indications:<ref name="PrioriBlomström-Lundqvist2015">{{cite journal|last1=Priori|first1=Silvia G.|last2=Blomström-Lundqvist|first2=Carina|last3=Mazzanti|first3=Andrea|last4=Blom|first4=Nico|last5=Borggrefe|first5=Martin|last6=Camm|first6=John|last7=Elliott|first7=Perry Mark|last8=Fitzsimons|first8=Donna|last9=Hatala|first9=Robert|last10=Hindricks|first10=Gerhard|last11=Kirchhof|first11=Paulus|last12=Kjeldsen|first12=Keld|last13=Kuck|first13=Karl-Heinz|last14=Hernandez-Madrid|first14=Antonio|last15=Nikolaou|first15=Nikolaos|last16=Norekvål|first16=Tone M.|last17=Spaulding|first17=Christian|last18=Van Veldhuisen|first18=Dirk J.|title=2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death|journal=European Heart Journal|volume=36|issue=41|year=2015|pages=2793–2867|issn=0195-668X|doi=10.1093/eurheartj/ehv316}}</ref><ref name="De FerrariDusi2015">{{cite journal|last1=De Ferrari|first1=Gaetano M.|last2=Dusi|first2=Veronica|last3=Spazzolini|first3=Carla|last4=Bos|first4=J. Martijn|last5=Abrams|first5=Dominic J.|last6=Berul|first6=Charles I.|last7=Crotti|first7=Lia|last8=Davis|first8=Andrew M.|last9=Eldar|first9=Michael|last10=Kharlap|first10=Maria|last11=Khoury|first11=Asaad|last12=Krahn|first12=Andrew D.|last13=Leenhardt|first13=Antoine|last14=Moir|first14=Christopher R.|last15=Odero|first15=Attilio|last16=Olde Nordkamp|first16=Louise|last17=Paul|first17=Thomas|last18=Rosés i Noguer|first18=Ferran|last19=Shkolnikova|first19=Maria|last20=Till|first20=Jan|last21=Wilde|first21=Arthur A.M.|last22=Ackerman|first22=Michael J.|last23=Schwartz|first23=Peter J.|title=Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation|volume=131|issue=25|year=2015|pages=2185–2193|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.115.015731}}</ref><ref name="WildeBhuiyan2008">{{cite journal|last1=Wilde|first1=Arthur A.M.|last2=Bhuiyan|first2=Zahurul A.|last3=Crotti|first3=Lia|last4=Facchini|first4=Mario|last5=De Ferrari|first5=Gaetano M.|last6=Paul|first6=Thomas|last7=Ferrandi|first7=Chiara|last8=Koolbergen|first8=Dave R.|last9=Odero|first9=Attilio|last10=Schwartz|first10=Peter J.|title=Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia|journal=New England Journal of Medicine|volume=358|issue=19|year=2008|pages=2024–2029|issn=0028-4793|doi=10.1056/NEJMoa0708006}}</ref> | |||
**Patients who experience recurrent [[symptoms]] and/or [[implantable cardioverter-defibrillator]] ([[ICD]]) shocks despite optimal medical therapy | |||
**Patients who are intolerant or have contraindications to [[beta blockers]] | |||
*Limitations: | |||
**Complexity of the surgical procedure | |||
**Requirement of a specialised surgical centre | |||
**Complications, such as:<ref name="Waddell-SmithErtresvaag2015">{{cite journal|last1=Waddell-Smith|first1=Kathryn E.|last2=Ertresvaag|first2=Kjetil N.|last3=Li|first3=Jian|last4=Chaudhuri|first4=Krish|last5=Crawford|first5=Jackie R.|last6=Hamill|first6=James K.|last7=Haydock|first7=David|last8=Skinner|first8=Jonathan R.|title=Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation: Arrhythmia and Electrophysiology|volume=8|issue=5|year=2015|pages=1151–1158|issn=1941-3149|doi=10.1161/CIRCEP.115.003159}}</ref> | |||
***[[Horner's syndrome]] | |||
***[[Pneumothorax]] | |||
*In spite of the side-effects and complications, the procedure was safe and satisfactory among the vast majority of patients. | |||
*The | ===Catheter ablation=== | ||
*The onset of [[CPVT]] may be initiated from [[purkinje cells]] and successful [[catheter ablation]] has been reported.<ref name="PrioriWilde2013">{{cite journal|last1=Priori|first1=Silvia G.|last2=Wilde|first2=Arthur A.|last3=Horie|first3=Minoru|last4=Cho|first4=Yongkeun|last5=Behr|first5=Elijah R.|last6=Berul|first6=Charles|last7=Blom|first7=Nico|last8=Brugada|first8=Josep|last9=Chiang|first9=Chern-En|last10=Huikuri|first10=Heikki|last11=Kannankeril|first11=Prince|last12=Krahn|first12=Andrew|last13=Leenhardt|first13=Antoine|last14=Moss|first14=Arthur|last15=Schwartz|first15=Peter J.|last16=Shimizu|first16=Wataru|last17=Tomaselli|first17=Gordon|last18=Tracy|first18=Cynthia|last19=Ackerman|first19=Michael|last20=Belhassen|first20=Bernard|last21=Estes|first21=N. A. Mark|last22=Fatkin|first22=Diane|last23=Kalman|first23=Jonathan|last24=Kaufman|first24=Elizabeth|last25=Kirchhof|first25=Paulus|last26=Schulze-Bahr|first26=Eric|last27=Wolpert|first27=Christian|last28=Vohra|first28=Jitendra|last29=Refaat|first29=Marwan|last30=Etheridge|first30=Susan P.|last31=Campbell|first31=Robert M.|last32=Martin|first32=Edward T.|last33=Quek|first33=Swee Chye|title=Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes|journal=EP Europace|volume=15|issue=10|year=2013|pages=1389–1406|issn=1532-2092|doi=10.1093/europace/eut272}}</ref> | |||
* | *[[Catheter ablation]] of the bidirectional [[VPC]]s that trigger [[VF]] has been reported and this procedure could become an adjunctive therapy in patients with refractory [[CPVT]].<ref name="KaneshiroNaruse2012">{{cite journal|last1=Kaneshiro|first1=Takashi|last2=Naruse|first2=Yoshihisa|last3=Nogami|first3=Akihiko|last4=Tada|first4=Hiroshi|last5=Yoshida|first5=Kentaro|last6=Sekiguchi|first6=Yukio|last7=Murakoshi|first7=Nobuyuki|last8=Kato|first8=Yoshiaki|last9=Horigome|first9=Hitoshi|last10=Kawamura|first10=Mihoko|last11=Horie|first11=Minoru|last12=Aonuma|first12=Kazutaka|title= | ||
Successful Catheter Ablation of Bidirectional Ventricular Premature Contractions Triggering Ventricular Fibrillation in Catecholaminergic Polymorphic Ventricular Tachycardia With | |||
RyR2 | |||
Mutation | |||
|journal=Circulation: Arrhythmia and Electrophysiology|volume=5|issue=1|year=2012|issn=1941-3149|doi=10.1161/CIRCEP.111.966549}}</ref> | |||
*Further evidence and experiences are required for its recommendation. | |||
==References== | ==References== |
Revision as of 15:00, 23 July 2020
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Catecholaminergic polymorphic ventricular tachycardia surgery On the Web |
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia surgery |
FDA on Catecholaminergic polymorphic ventricular tachycardia surgery |
CDC on Catecholaminergic polymorphic ventricular tachycardia surgery |
Catecholaminergic polymorphic ventricular tachycardia surgery in the news |
Blogs on Catecholaminergic polymorphic ventricular tachycardia surgery |
Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Surgery is not the first-line treatment option for patients with catecholaminergic polymorphic ventricular tachycardia. Sympathectomy is usually reserved for patients who experience recurrent symptoms and/or implantable cardioverter-defibrillator (ICD) shocks despite optimal medical therapy or in those who are intolerant or have contraindications to beta blockers
Surgery
Sympathectomy
- Left cardiac sympathetic denervation, where a portion of the sympathetic chain is surgically or endoscopically resected, and bilateral thoracoscopic sympathectomy have reported to be useful therapeutic methods for suppressing ventricular arrhythmias in CPVT patients.[1][2][3][4]
- Indications:[1][5][6]
- Patients who experience recurrent symptoms and/or implantable cardioverter-defibrillator (ICD) shocks despite optimal medical therapy
- Patients who are intolerant or have contraindications to beta blockers
- Limitations:
- Complexity of the surgical procedure
- Requirement of a specialised surgical centre
- Complications, such as:[7]
- In spite of the side-effects and complications, the procedure was safe and satisfactory among the vast majority of patients.
Catheter ablation
- The onset of CPVT may be initiated from purkinje cells and successful catheter ablation has been reported.[8]
- Catheter ablation of the bidirectional VPCs that trigger VF has been reported and this procedure could become an adjunctive therapy in patients with refractory CPVT.[9]
- Further evidence and experiences are required for its recommendation.
References
- ↑ 1.0 1.1 Priori, Silvia G.; Blomström-Lundqvist, Carina; Mazzanti, Andrea; Blom, Nico; Borggrefe, Martin; Camm, John; Elliott, Perry Mark; Fitzsimons, Donna; Hatala, Robert; Hindricks, Gerhard; Kirchhof, Paulus; Kjeldsen, Keld; Kuck, Karl-Heinz; Hernandez-Madrid, Antonio; Nikolaou, Nikolaos; Norekvål, Tone M.; Spaulding, Christian; Van Veldhuisen, Dirk J. (2015). "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". European Heart Journal. 36 (41): 2793–2867. doi:10.1093/eurheartj/ehv316. ISSN 0195-668X.
- ↑ Schneider, Heike E.; Steinmetz, Michael; Krause, Ulrich; Kriebel, Thomas; Ruschewski, Wolfgang; Paul, Thomas (2012). "Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome". Clinical Research in Cardiology. 102 (1): 33–42. doi:10.1007/s00392-012-0492-7. ISSN 1861-0684.
- ↑ Scott, P.A. (October 2008). "Successful treatment of catecholaminergic polymorphic ventricular tachycardia with bilateral thoracoscopic sympathectomy". Heart Rhythm. 5 (10): 1461–1463. doi:10.1016/j.hrthm.2008.07.007. PMID 18760972. Unknown parameter
|coauthors=
ignored (help) - ↑ Collura, Christopher A.; Johnson, Jonathan N.; Moir, Christopher; Ackerman, Michael J. (2009). "Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery". Heart Rhythm. 6 (6): 752–759. doi:10.1016/j.hrthm.2009.03.024. ISSN 1547-5271.
- ↑ De Ferrari, Gaetano M.; Dusi, Veronica; Spazzolini, Carla; Bos, J. Martijn; Abrams, Dominic J.; Berul, Charles I.; Crotti, Lia; Davis, Andrew M.; Eldar, Michael; Kharlap, Maria; Khoury, Asaad; Krahn, Andrew D.; Leenhardt, Antoine; Moir, Christopher R.; Odero, Attilio; Olde Nordkamp, Louise; Paul, Thomas; Rosés i Noguer, Ferran; Shkolnikova, Maria; Till, Jan; Wilde, Arthur A.M.; Ackerman, Michael J.; Schwartz, Peter J. (2015). "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 131 (25): 2185–2193. doi:10.1161/CIRCULATIONAHA.115.015731. ISSN 0009-7322.
- ↑ Wilde, Arthur A.M.; Bhuiyan, Zahurul A.; Crotti, Lia; Facchini, Mario; De Ferrari, Gaetano M.; Paul, Thomas; Ferrandi, Chiara; Koolbergen, Dave R.; Odero, Attilio; Schwartz, Peter J. (2008). "Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia". New England Journal of Medicine. 358 (19): 2024–2029. doi:10.1056/NEJMoa0708006. ISSN 0028-4793.
- ↑ Waddell-Smith, Kathryn E.; Ertresvaag, Kjetil N.; Li, Jian; Chaudhuri, Krish; Crawford, Jackie R.; Hamill, James K.; Haydock, David; Skinner, Jonathan R. (2015). "Physical and Psychological Consequences of Left Cardiac Sympathetic Denervation in Long-QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation: Arrhythmia and Electrophysiology. 8 (5): 1151–1158. doi:10.1161/CIRCEP.115.003159. ISSN 1941-3149.
- ↑ Priori, Silvia G.; Wilde, Arthur A.; Horie, Minoru; Cho, Yongkeun; Behr, Elijah R.; Berul, Charles; Blom, Nico; Brugada, Josep; Chiang, Chern-En; Huikuri, Heikki; Kannankeril, Prince; Krahn, Andrew; Leenhardt, Antoine; Moss, Arthur; Schwartz, Peter J.; Shimizu, Wataru; Tomaselli, Gordon; Tracy, Cynthia; Ackerman, Michael; Belhassen, Bernard; Estes, N. A. Mark; Fatkin, Diane; Kalman, Jonathan; Kaufman, Elizabeth; Kirchhof, Paulus; Schulze-Bahr, Eric; Wolpert, Christian; Vohra, Jitendra; Refaat, Marwan; Etheridge, Susan P.; Campbell, Robert M.; Martin, Edward T.; Quek, Swee Chye (2013). "Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes". EP Europace. 15 (10): 1389–1406. doi:10.1093/europace/eut272. ISSN 1532-2092.
- ↑ Kaneshiro, Takashi; Naruse, Yoshihisa; Nogami, Akihiko; Tada, Hiroshi; Yoshida, Kentaro; Sekiguchi, Yukio; Murakoshi, Nobuyuki; Kato, Yoshiaki; Horigome, Hitoshi; Kawamura, Mihoko; Horie, Minoru; Aonuma, Kazutaka (2012). "Successful Catheter Ablation of Bidirectional Ventricular Premature Contractions Triggering Ventricular Fibrillation in Catecholaminergic Polymorphic Ventricular Tachycardia With
RyR2
Mutation". Circulation: Arrhythmia and Electrophysiology. 5 (1). doi:10.1161/CIRCEP.111.966549. ISSN 1941-3149. line feed character in
|title=
at position 179 (help)